Gilead Sciences, Inc. (0QYQ.IL)
| Previous Close | 68.57 |
| Open | 68.78 |
| Bid | 66.32 x N/A |
| Ask | 73.05 x N/A |
| Day's Range | 68.63 - 69.94 |
| 52 Week Range | 62.14 - 87.53 |
| Volume | |
| Avg. Volume | 33,321 |
| Market Cap | 87.117B |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | 16.07 |
| EPS (TTM) | 4.35 |
| Earnings Date | Aug 08, 2024 |
| Forward Dividend & Yield | 3.00 (3.81%) |
| Ex-Dividend Date | Sept 14, 2023 |
| 1y Target Est | N/A |
ACCESSWIREGilead Benefit Helps Employees Navigate Cancer Care
NORTHAMPTON, MA / ACCESSWIRE / July 1, 2024 / Jim Candler had a successful 40-year career in system operations before coming to Gilead three years ago to bring his tech expertise to the Human Resources team. "I was hired at 71 years old. What does ...
Insider MonkeyShould You Hold Gilead Sciences (GILD)?
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) appreciated 10.17% outperforming the Russell 1000 Value Index’s 8.99%. Stock selection in the Information Technology and Communication Services sectors was the […]
Simply Wall St.Recent uptick might appease Gilead Sciences, Inc. (NASDAQ:GILD) institutional owners after losing 4.6% over the past year
Key Insights Institutions' substantial holdings in Gilead Sciences implies that they have significant influence over...
